Reimbursement & Market Access
Our experts have a combined experience of 35 years helping healthcare companies demonstrating the value of their products, developing access to market and increasing sales.
Initial Market Research
Our experts will pinpoint the 3-5 most promising markets for the product to be validated by the analysis of the Diagnostic/Product Potential Towers methodology.
The Reimbursement Analysis determines the ideal positioning and pricing model, answers what economic clinical evidence needs to be collected in the clinical strategy for achieving and sustaining coverage/reimbursement for the product and lists the factors that could affect the perception of value of the diagnostic in each of the markets addressed by the DPT/PPT.
Diagnostic/Product Potential Tower (DPT or PPT)
Diagnostic Potential Tower (DPT) tool answers the questions: what is the actual potential market, how to activate this market and how to grow sales in it?
Commercial Due Diligence
Applies current market data and analysis to translate the product’s clinical and economic benefits into financial value for investors. This approach calculates the targeted market size and potential, validates unmet needs and supports the estimation of sales timelines.
Budget Impact Model (BIM)
The Budget Impact Model (BIM) is a strategic selling tool that demonstrates the financial impact of investing in the device while considering its clinical and economic benefits to the purchaser. It also highlights the key clinical and economic data required to fully assess the value of the device. With the BIM companies become partners, and not sellers, to purchasers by significantly improving the market differentiation and increasing the potential value of the product in the market.